NFKB1 and inflammatory bowel disease: Indeed, within this study CpdA and ZK216348 have shown desirable trans-repressive, and therefore anti-inflammatory, action in intestinal epithelial cells by inhibiting the activity of NF-κB, a transcription factor associated with numerous pro-inflammatory genes in IBD [38].